a month ago
JAZZ
AnalystsDavid AmsellemDavid Amsellem's Stock Forecasts
AnalystsDavid Amsellem
Analyst Ranking
Top 4%
#184 out of 5314 analysts
Average Return
+21.83%
Win Rate
68%103 out of 151
Risk vs Reward
Poor
Good
David Amsellem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Indivior Pharmaceuticals IncINDV | +224.06% | $9.89 | $32.05 | 2025-03-06 - 2026-03-05 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +222.28% | $2.02 | $6.51 | 2023-05-08 - 2024-05-07 | Strong Buy |
Indivior Pharmaceuticals IncINDV | +218.77% | $7.46 | $23.78 | 2024-10-11 - 2025-10-10 | Strong Buy |
Horizon Therapeutics Public Ltd CoHZNP | +189.77% | $31.56 | $91.45 | 2020-04-14 - 2021-04-14 | Strong Buy |
Indivior Pharmaceuticals IncINDV | +179.22% | $9.00 | $25.13 | 2024-10-25 - 2025-10-24 | Strong Buy |
David Amsellem Analyst Color
Get additional color on David Amsellem's coverage of popular stocks
2 months ago
ABBV
2 months ago
NBIX
2 months ago
CORT
2 months ago
TEVA
4 months ago
JAZZ
4 months ago
TEVA
5 months ago
ABBV
6 months ago
AXSM
6 months ago
TEVA
7 months ago
JAZZ
8 months ago
AQST
8 months ago
ABBV
8 months ago
INDV
8 months ago
AMRX
8 months ago
NBIX
9 months ago
SUPN
a year ago
NBIX
a year ago
CORT
a year ago
CORT
a year ago
TEVA
2 years ago
AMRX
2 years ago
INDV
2 years ago
CORT
2 years ago
NBIX
David Amsellem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Abbvie IncABBV | 7 | Strong Buy | $298.00 | +14.15% | Reiterates | 12 days ago |
Jazz Pharmaceuticals PLCJAZZ | 12 | Strong Buy | $301.00 | +23.63% | Maintains | a month ago |
Biogen IncBIIB | 6 | Strong Buy | $225.00 | +4.11% | Reiterates | 2 months ago |
Amgen IncAMGN | 8 | Strong Buy | $427.00 | +14.13% | Maintains | 2 months ago |
Amphastar Pharmaceuticals IncAMPH | 9 | Hold | $21.00 | +6.92% | Reiterates | 2 months ago |
Definium Therapeutics IncDFTX | 2 | Strong Buy | $48.00 | +8.62% | Maintains | 2 months ago |
Neurocrine Biosciences IncNBIX | 10 | Strong Buy | $207.00 | +18.79% | Maintains | 2 months ago |
Corcept Therapeutics IncCORT | 9 | Strong Buy | $88.00 | -2.45% | Maintains | 2 months ago |
Teva Pharmaceutical Industries LtdTEVA | 10 | Strong Buy | $42.00 | +21.25% | Reiterates | 2 months ago |
Organon & CoOGN | 7 | Hold | $14.00 | +3.32% | Upgrades | 2 months ago |
Alkermes PLCALKS | 9 | Strong Buy | $43.00 | -21.22% | Maintains | 3 months ago |
Pelthos Therapeutics IncPTHS | 1 | Strong Buy | $48.00 | +86.26% | Initiates Coverage On | 4 months ago |
Bristol Myers Squibb CoBMY | 3 | Strong Buy | $75.00 | +29.02% | Maintains | 4 months ago |
Viatris IncVTRS | 8 | Hold | $12.00 | -28.14% | Maintains | 5 months ago |
Axsome Therapeutics IncAXSM | 4 | Strong Buy | $223.00 | -8.72% | Maintains | 6 months ago |
Fennec Pharmaceuticals IncFENC | 1 | Strong Buy | $18.00 | +68.22% | Initiates Coverage On | 6 months ago |
Esperion Therapeutics IncESPR | 1 | Strong Buy | $9.00 | +184.81% | Initiates Coverage On | 7 months ago |
Aquestive Therapeutics IncAQST | 2 | Strong Buy | $8.00 | +91.39% | Maintains | 8 months ago |
Xeris Biopharma Holdings IncXERS | 6 | Hold | $8.00 | -3.38% | Maintains | 8 months ago |
Indivior Pharmaceuticals IncINDV | 6 | Strong Buy | $41.00 | +3.02% | Reiterates | 8 months ago |
Amneal Pharmaceuticals IncAMRX | 5 | Strong Buy | $13.00 | -24.20% | Reiterates | 8 months ago |
Supernus Pharmaceuticals IncSUPN | 12 | Strong Buy | $65.00 | +35.28% | Upgrades | 9 months ago |
Sage Therapeutics IncSAGE | 2 | Hold | $8.50 | N/A | Downgrades | a year ago |
Collegium Pharmaceutical IncCOLL | 7 | Hold | $37.00 | N/A | Reiterates | a year ago |
Optinose IncOPTN | 3 | Hold | $9.00 | N/A | Downgrades | a year ago |
Intra Cellular Therapies IncITCI | 1 | Hold | $132.00 | N/A | Downgrades | a year ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Strong Buy | $13.00 | N/A | Maintains | a year ago |
Ani Pharmaceuticals IncANIP | 1 | Strong Buy | $68.00 | N/A | Initiates Coverage On | 2 years ago |
Revance Therapeutics IncRVNC | 7 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Bausch Health Companies IncBHC | 4 | Strong Sell | $3.00 | N/A | Downgrades | 2 years ago |
Pacira Biosciences IncPCRX | 7 | Strong Buy | $42.00 | N/A | Maintains | 2 years ago |
Ironwood Pharmaceuticals IncIRWD | 3 | Strong Buy | $21.00 | N/A | Maintains | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $45.00 | N/A | Downgrades | 3 years ago |
Tvardi Therapeutics IncTVRD | 3 | Hold | $12.00 | N/A | Downgrades | 3 years ago |
Harmony Biosciences Holdings IncHRMY | 3 | Strong Buy | $42.00 | N/A | Maintains | 3 years ago |
Eagle Pharmaceuticals IncEGRX | 2 | Strong Sell | $17.00 | N/A | Downgrades | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $285.00 | N/A | Initiates Coverage On | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Strong Buy | $110.00 | N/A | Maintains | 4 years ago |
Antares Pharma IncATRS | 1 | Hold | $5.60 | N/A | Downgrades | 4 years ago |
Endo International PLCENDPQ | 3 | Hold | $3.00 | N/A | Maintains | 4 years ago |
Biodelivery Sciences International IncBDSI | 1 | Hold | $5.60 | N/A | Downgrades | 4 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Hold | $8.00 | N/A | Downgrades | 5 years ago |
Evofem Biosciences IncEVFM | 1 | Strong Buy | $165.00 | N/A | Initiates Coverage On | 6 years ago |
Impax Laboratories IncIPXL | 1 | Hold | N/A | N/A | Upgrades | 9 years ago |
Societal Cdmo IncSCTL | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.